疑似自发性颅内低压初次脊髓造影阴性后重复造影的诊断价值
本研究为单中心回顾性研究,纳入71例初次脊髓造影阴性或未能定位的疑似自发性颅内低压患者,评价重复造影的诊断获益。结果显示重复造影明确或经临床支持定位脑脊液-静脉瘘的比例约为1/10。压力性或用力诱发头痛及生理盐水增量技术可能与阳性结果相关,值得前瞻验证。
要点
- 初次造影阴性或不能定位时,重复造影仍有约10%的临床支持定位率。
- 光子计数探测器CT在二次队列中检出了全部3例明确定位。
- 压力性或用力诱发头痛患者重复造影阳性率明显更高。
核心结论
- 初次脊髓造影阴性或未能定位后,重复造影可为约十分之一的患者提供明确或临床支持的定位。
- 明确定位率随Bern评分升高呈上升趋势,但差异无统计学意义。
研究设计与样本
- 回顾性单中心研究,主要队列71例既往造影阴性或未能定位的患者,次要队列13例既往可疑靶点治疗后仍未解决的患者。
- 参考标准包括治疗后症状改善对可疑发现提供临床支持。
关键影像表现/征象
- 主要队列中重复造影明确定位脑脊液-静脉瘘3例,可疑但治疗后改善4例。
- 次要队列中3例明确定位均使用光子计数探测器CT完成。
- 7例临床支持病例中全部使用了生理盐水增量技术。
诊断标准与关键数值
- 主要队列明确定位率3/71(4.2%;95%CI 0.9%-11.9%)。
- 临床支持定位率7/71(9.9%;95%CI 4.1%-19.3%)。
临床应用与阅片要点
- 压力性或用力诱发头痛的患者更适合考虑重复脊髓造影。
- 重复造影时使用生理盐水增量技术可能有助于提高阳性率。
- 光子计数探测器CT在二次队列中显示明显优势,条件允许时优先选用。
局限性
- 回顾性单中心研究,样本量有限,主要队列明确定位仅3例。
- Bern评分分层间差异不显著,可能存在检验效能不足。
- 次要队列仅有13例,光子计数探测器CT的优势有待更大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Patients with suspected spontaneous intracranial hypotension and no spinal epidural fluid collection may harbor a CSF-venous fistula (CVF). When an initial myelogram is negative or shows only a suspicious finding, the value of another examination is uncertain. We measured the clinically supported yield of repeat myelography and sought features associated with positivity.
MATERIALS AND METHODS: This retrospective single-center study evaluated 71 patients with an earlier negative or nonlocalizing myelogram and, secondarily, 13 whose earlier suspicious target remained unresolved after treatment. Repeat reports were classified as definite, suspicious, or negative. Improvement after treatment directed to a suspicious (but not definite) finding provided clinical support. Clinical, MRI, and procedural features, including Bern-score strata, were explored in the primary cohort.
RESULTS: In the primary cohort, repeat myelography definitively localized a CVF in 3/71 patients (4.2%; 95% CI, 0.9%-11.9%). Four additional patients had treatment-responsive suspicious findings, producing a clinically supported yield of 7/71 (9.9%; 95% CI, 4.1%-19.3%). Clinically supported yield rose from 7.3% (3/41) at Bern scores of 0-2 to 12.5% (2/16) at 3-4 and 16.7% (2/12) at 5 or greater (P = .55). In the secondary cohort, 3/13 patients had definite localizations, all with photon-counting detector CT (PCCT). Across both cohorts, the yield was 10/84 (11.9%). Saline augmentation was used in 7/7 clinically supported cases and 31/59 negative repeats (P = .02). In post hoc analysis, yield was 5/19 with pressure- or exertion-provoked headache and 2/47 without this phenotype (relative risk, 6.18; 95% CI, 1.31-29.16; P = .02).
CONCLUSIONS: After an earlier negative or nonlocalizing study, repeat myelography provided a definite or clinically supported localization in approximately 1 in 10 patients. Yield rose numerically with Bern score, but differences were not significant. All 3 definite localizations in the smaller secondary cohort were made with PCCT. Pressure- or exertion-provoked headache and saline augmentation warrant prospective evaluation.
引用
- Callen, Jenkins, Bhaumik, et al. Diagnostic Yield of Repeat Myelography After an Initial Negative Study in Patients With Suspected Spontaneous Intracranial Hypotension. AJNR Am J Neuroradiol. 2026. PMID: 42778499. doi:10.3174/ajnr.A9647
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。